MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 556.50
+7.50 (1.37%)
Jul 24, 2026, 5:29 PM CET
MedCap AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,319 | 2,151 | 1,856 | 1,615 | 1,154 | 949.6 | |
Revenue Growth (YoY) | 18.96% | 15.91% | 14.94% | 39.89% | 21.54% | 12.47% |
Cost of Revenue | 944.9 | 893.6 | 763.3 | 671.4 | 446.8 | 357.7 |
Gross Profit | 1,374 | 1,257 | 1,092 | 943.1 | 707.3 | 591.9 |
Selling, General & Admin | 839.3 | 791.5 | 698.5 | 601.1 | 443.5 | 384.6 |
Depreciation & Amortization Expenses | 176.4 | 153.4 | 115.4 | 104.1 | 87.8 | 75.5 |
Other Operating Expenses | 12.9 | 9.5 | 6.4 | 10.6 | 5.2 | 4.7 |
Total Operating Expenses | 1,029 | 954.4 | 820.3 | 715.8 | 536.5 | 464.8 |
Operating Income | 345.5 | 302.9 | 272.3 | 227.5 | 170.9 | 127 |
Interest Income | 17.1 | 17.6 | 8.3 | 10.4 | 2.3 | 1.7 |
Interest Expense | -48.8 | -31.5 | -19 | -15.6 | -21.2 | -11.8 |
Total Non-Operating Income (Expense) | -31.7 | -13.9 | -10.7 | -5.2 | -18.9 | -10.1 |
Pretax Income | 313.8 | 289 | 261.6 | 222.3 | 152 | 116.9 |
Provision for Income Taxes | 72.5 | 68.3 | 52.3 | 49.8 | 34 | 18.9 |
Net Income | 241.3 | 220.7 | 209.3 | 172.5 | 118 | 98 |
Minority Interest in Earnings | 0.6 | 0.9 | 1.9 | 0.3 | 0.4 | 1.6 |
Net Income to Common | 240.8 | 219.8 | 207.4 | 172.2 | 117.6 | 96.5 |
Net Income Growth | 21.25% | 5.98% | 20.44% | 46.43% | 21.87% | 58.46% |
Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 15 |
Shares Change (YoY) | 0.12% | 0.94% | 0.05% | 0.33% | 0.04% | 3.10% |
EPS (Basic) | 16.00 | 14.70 | 14.00 | 11.60 | 7.90 | 6.50 |
EPS (Diluted) | 16.00 | 14.70 | 14.00 | 11.60 | 7.90 | 6.50 |
EPS Growth | 20.30% | 5.00% | 20.69% | 46.84% | 21.54% | 54.76% |
Free Cash Flow | 363.8 | 317 | 318.3 | 205.9 | 59.2 | 71 |
Free Cash Flow Growth | 21.96% | -0.41% | 54.59% | 247.80% | -16.62% | -31.93% |
Free Cash Flow Per Share | 24.25 | 21.13 | 21.41 | 13.86 | 4.00 | 4.80 |
Gross Margin | 59.25% | 58.45% | 58.87% | 58.41% | 61.29% | 62.33% |
Operating Margin | 14.90% | 14.08% | 14.67% | 14.09% | 14.81% | 13.37% |
Profit Margin | 10.41% | 10.26% | 11.28% | 10.68% | 10.22% | 10.32% |
FCF Margin | 15.69% | 14.74% | 17.15% | 12.75% | 5.13% | 7.48% |
EBITDA | 522 | 456.2 | 387.7 | 331.5 | 258.7 | 202.5 |
EBITDA Margin | 22.51% | 21.21% | 20.89% | 20.53% | 22.42% | 21.32% |
EBIT | 345.5 | 302.9 | 272.3 | 227.5 | 170.9 | 127 |
EBIT Margin | 14.90% | 14.08% | 14.67% | 14.09% | 14.81% | 13.37% |
Effective Tax Rate | 23.10% | 23.63% | 19.99% | 22.40% | 22.37% | 16.17% |